Schierbeek H, Bijsterveld K, Chapman T E, van Luijk W H, Reijngoud D J, Berger R
Nutrition Science, Nestlé Research Centre, Nestec Ltd., Lausanne, Switzerland.
Clin Chim Acta. 1990 Oct 31;191(1-2):39-47. doi: 10.1016/0009-8981(90)90056-x.
A stable isotope dilution method was developed for the determination of cystine in granulocytes. Granulocytes were isolated from blood samples of treated cystinosis patients. Cystine in the granulocyte suspension was decoupled from proteins and converted to cysteine by treatment with a tri-butyl phosphine solution. Tertiary butyldimethyl silyl derivatives were prepared and analyzed by gas chromatography/mass spectrometry. Selective ion monitoring was carried out at m/z 304.3 (M-159 and m/z 406.4 (M-57) for the natural, and at m/z 306.3 and 408.4 for the labelled compound. [3,3,3',3'-2H]-DL-cystine was used as internal standard for the isotope dilution analysis. Concentrations of cystine in granulocytes could be accurately measured. There was a distinct difference in cystine concentrations in healthy individuals and treated patients.
开发了一种稳定同位素稀释法用于测定粒细胞中的胱氨酸。从接受治疗的胱氨酸病患者的血样中分离出粒细胞。通过用三丁基膦溶液处理,使粒细胞悬浮液中的胱氨酸与蛋白质解离并转化为半胱氨酸。制备叔丁基二甲基甲硅烷基衍生物并通过气相色谱/质谱法进行分析。对天然化合物在m/z 304.3(M-159)和m/z 406.4(M-57)处进行选择性离子监测,对标记化合物在m/z 306.3和408.4处进行选择性离子监测。[3,3,3',3'-2H]-DL-胱氨酸用作同位素稀释分析的内标。可以准确测量粒细胞中胱氨酸的浓度。健康个体和接受治疗的患者的胱氨酸浓度存在明显差异。